- Home
- MU vs MRK Comparison
MU vs MRK Comparison
Compare MU & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MU | MRK |
|---|---|---|
| Founded | 1978 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.0B | 260.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MU | MRK |
|---|---|---|
| Price | $258.45 | $97.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 32 | 15 |
| Target Price | ★ $215.81 | $110.33 |
| AVG Volume (30 Days) | ★ 25.5M | 16.0M |
| Earning Date | 12-17-2025 | 10-30-2025 |
| Dividend Yield | 0.18% | ★ 3.51% |
| EPS Growth | ★ 984.29 | 58.08 |
| EPS | ★ 7.59 | 7.56 |
| Revenue | $37,378,000,000.00 | ★ $64,235,000,000.00 |
| Revenue This Year | $50.61 | $1.97 |
| Revenue Next Year | $16.26 | $4.96 |
| P/E Ratio | $33.26 | ★ $12.82 |
| Revenue Growth | ★ 48.85 | 1.68 |
| 52 Week Low | $61.54 | $73.31 |
| 52 Week High | $260.58 | $105.84 |
Technical Indicators
Market Signals| Indicator | MU | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 64.43 | 52.63 |
| Support Level | $223.33 | $96.06 |
| Resistance Level | $244.37 | $99.85 |
| Average True Range (ATR) | 11.88 | 2.68 |
| MACD | 1.46 | -0.83 |
| Stochastic Oscillator | 99.55 | 27.01 |
Price Performance
Historical ComparisonAbout MU Micron Technology Inc.
Micron is one of the largest semiconductor companies in the world, specializing in memory and storage chips. Its primary revenue stream comes from dynamic random access memory, or DRAM, and it also has minority exposure to not-and or NAND, flash chips. Micron serves a global customer base, selling chips into data centers, mobile phones, consumer electronics, and industrial and automotive applications. The firm is vertically integrated.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).